SMTL ID : 6j1l.3 (2 other biounits)

Crystal Structure Analysis of the ROR gamma(C455E)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

monomer

Ligands

1 x B6L: 2-[4-(ethylsulfonyl)phenyl]-N-[2'-fluoro-4'-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)[1,1'-biphenyl]-4-yl]acetamide(Non-covalent)

B6L.1: 19 residues within 4Å: Chain A: Q.46, L.47, L.52, W.77, C.80, H.83, L.84, R.124, M.125, R.127, A.128, F.137, F.138, F.148, L.151, L.156, I.157, I.160, H.239 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.47, A:H.83, A:L.84, A:R.124, A:A.128, A:F.137, A:F.148 Hydrogen bonds: A:F.137 Water bridges: A:E.139 pi-Stacking: A:F.138

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhang, Y. et al., Discovery and Characterization of XY101, a Potent, Selective, and Orally Bioavailable ROR gamma Inverse Agonist for Treatment of Castration-Resistant Prostate Cancer. J.Med.Chem. (2019)

Release Date

2019-05-01

Peptides

Nuclear receptor ROR-gamma: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

Nuclear receptor ROR-gamma

Related Entries With Identical Sequence